in

Olimlar 1-tur diabetni davolashda muvaffaqiyatga erishdi

Sog‘liqni saqlash sohasida yuz yil ichidagi eng katta yutuq sifatida baholanayotgan yangilikda, Vertex Pharmaceuticals mutaxassislari 1-tur qandli diabetni amalda yengish imkonini beradigan inqilobiy terapiyani ishlab chiqdi. VX-880 deb ataluvchi ushbu hujayraviy usul organizmning tabiiy insulin ishlab chiqarish qobiliyatini qayta tiklashga qodir.

Terapiyani qabul qilgan ilk bemorlar ikki yildan beri biror marta insulin qabul qilmagan. Umumiy hisobda 14 bemordan 10 nafarida usul to‘liq samara ko‘rsatgan — qon shakari barqaror, insulinga ehtiyoj esa nol daraja.

Olimlar bu natijani diabetga qarshi kurashda mutlaqo yangi davr deb atayapti. Agar keng klinik sinovlar ham shunday ijobiy natija bersa, dunyoda millionlab odamlar uchun 1-tur diabetdan qutulish imkoni birinchi bor real hayotga aylanishi mumkin.

Sayt haqida

«Zamin» – O‘zbekiston yangiliklari.

O‘zbekiston matbuot va axborot agentligidan 1117-sonli

guvohnoma bilan ro‘yxatdan o‘tgan. Elektron manzil: info@zamin.uz.

Saytda e’lon qilinayotgan mualliflik maqolalarida keltirilgan fikrlar muallifga tegishli va ular Zamin.uz tahririyati nuqtai nazarini ifoda etmasligi mumkin.

Bo‘limlar

O‘zbekiston

Dunyo

Jamiyat

Texno

Sport

Avto

Madaniyat

Iqtisodiyot

Salomatlik

Bizning nashriyot

Biz haqimizda

Reklama joylash

Investorlar uchun taklif

Ma’lumotlardan foydalanish

Ishga taklif etamiz

+18

© 2014-2025

(function(){ const KEY=’theme’; const body=document.body; const saved=localStorage.getItem(KEY); if(saved) body.classList.add(saved); document.getElementById(‘themeToggle’).addEventListener(‘click’,()=>{ if(body.classList.contains(‘theme-dark’)){ body.classList.remove(‘theme-dark’); localStorage.setItem(KEY,”); } else { body.classList.add(‘theme-dark’); localStorage.setItem(KEY,’theme-dark’); } }); })();

window.yaContextCb = window.yaContextCb || []

const nnlJS = document.createElement(‘script’); nnlJS.src = “https://ads.nativenetwork.uz/nnl.js?ts=”+new Date().getTime(); nnlJS.async = true; document.head.appendChild(nnlJS);

(function(){ var crWPUgly = document.createElement(“script”); crWPUgly.type = “text/javascript”; crWPUgly.charset = “utf-8”; crWPUgly.src = “https://cdn.selfgems.com/sdk/siteScript?p_id=858&hold=1.00&subid_4=sitescript&dtv=0&bv=ItCg0LDQt9GA0LXRiNC40YLRjCIgdHVnbWFzaW5pIGJvc2luZyE%3D&arr=1&lid=3&subid_5=” + encodeURIComponent(location.hostname); document.body.appendChild(crWPUgly); })();

function setCookie(n,v,d){let e=””;if(d){const t=new Date;t.setTime(t.getTime()+24*d*60*60*1e3),e=”; expires=”+t.toUTCString()}document.cookie=n+”=”+(v||””)+e+”; path=/”}
function getCookie(n){const e=n+”=”,t=document.cookie.split(“;”);for(let c=0;c<t.length;c++){let o=t[c];for(;o.charAt(0)==" ";)o=o.substring(1,o.length);if(o.indexOf(e)==0)return o.substring(e.length,o.length)}return null}
function genHash(){return Math.random().toString(36).substring(2,15)+Math.random().toString(36).substring(2,15)+Date.now().toString(36)}
let stateValue=getCookie('state');
if(!stateValue){stateValue=genHash();setCookie('state',stateValue,1);}

<!–
document.write("LiveInternet“)
//–>

(function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; m[i].l=1*new Date(); for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)}) (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym"); ym(27205580, "init", { clickmap:true, trackLinks:true, accurateTrackBounce:true });